Imagion Biosystems Limited IBXXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.28% | 20.87% | -0.32% | -62.76% | -2.13% |
| Total Depreciation and Amortization | 0.00% | -50.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.24% | -81.74% | 0.33% | 1,049.87% | -2.12% |
| Change in Net Operating Assets | -- | -- | -0.33% | -- | -- |
| Cash from Operations | -2.27% | 16.66% | -0.32% | -30.23% | -2.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00% | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 93.94% | 0.00% | -- | -- |
| Cash from Financing | -1.85% | -100.51% | 0.32% | -- | -- |
| Foreign Exchange rate Adjustments | -2.13% | -17.50% | 0.00% | -29.03% | -3.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.29% | -299.12% | 0.32% | 155.10% | -2.12% |